UN Agency To Manufacture Covid-19 Pills for Poor Nations

A United Nations-backed agency, Medicines Patent Pool, has struck a deal for nearly 30 generic drug makers to manufacture low-cost versions of Merck & Co’s COVID-19 pill, molnupiravir for poorer nations. <br />A Reuters report stated that the deal, negotiated by the UN-backed organisation with Merck, would expand output by increasing the number of companies that would produce the drug. <br />The new agreement allows 27 generic drug makers from India, China and other countries in Africa, Asia and the Middle East to produce ingredients and the finished drug. <br />The MPP stated that the deal stipulated that the pill would be distributed to 105 less-developed nations.